Combination Therapy of Bone Marrow Mesenchymal Stromal Cells and Azathioprine Not Affect the Clinical Course Luminal Crohn's Disease

被引：0
|
作者：
Knyazev, Oleg [1 ]
Kagramanova, Anna [1 ]
Fadeeva, Nina [1 ]
机构：
[1] Moscow Clin Res Ctr, Moscow, Russia
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-123
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Combination therapy of bone marrow mesenchymal stromal cells and azathioprine not affect the clinical course luminal Crohn's disease
    Knyazev, O.
    Parfenov, A.
    Fadeeva, N.
    Konoplyannikov, A.
    Kagramanova, A.
    Ruchkina, I.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S352 - S353
  • [2] Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy
    Knyazev, O. V.
    Kagramanova, A. V.
    Fadeeva, N. A.
    Lishchinskaya, A. A.
    Boldyreva, O. N.
    Noskova, K. K.
    Gudkova, R. B.
    Konoplyannikov, A. G.
    Parfenov, A. I.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (02): : 47 - 52
  • [3] Dynamics of proinflammatory cytokines in patients with Crohn's disease who received combined therapy with mesenchymal stromal cells of bone marrow and azathioprine
    Knyazev, O.
    Fadeeva, N.
    Babayan, A.
    Dobroluybova, E.
    Donchenko, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S437 - S437
  • [4] Mesenchymal Stromal Cells of Bone Marrow Reduce the Risk of Postoperative Recurrence of Crohn's Disease
    Knyazev, Oleg
    Kagramanova, Anna
    Konoplyannikov, Anatoliy
    Kulakov, Dmitriy
    Korneeva, Irina
    Zvyaglova, Mariya
    Babayan, Anait
    Parfenov, Asfold
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S13 - S13
  • [5] Mesenchymal stromal cells of bone marrow reduce the risk of postoperative recurrence of Crohn's disease
    Knyazev, O.
    Kagramanova, A. V.
    Lishchinskaya, A.
    Parfenov, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S513 - S514
  • [6] The duration of clinical remission in patients with Crohn's disease depends on the frequency of administration of mesenchymal stromal cells of the bone marrow
    Knyazev, O.
    Kagramanova, A. V.
    Lishchinskaya, A.
    Li, I.
    Shkurko, T.
    Veselov, A.
    Fadeeva, N.
    Zhulina, E.
    Parfenov, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S306 - S306
  • [7] Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
    Ciccocioppo, Rachele
    Bernardo, Maria Ester
    Sgarella, Adele
    Maccario, Rita
    Avanzini, Maria Antonietta
    Ubezio, Cristina
    Minelli, Antonella
    Alvisi, Costanza
    Vanoli, Alessandro
    Calliada, Fabrizio
    Dionigi, Paolo
    Perotti, Cesare
    Locatelli, Franco
    Corazza, Gino Roberto
    GUT, 2011, 60 (06) : 788 - 798
  • [8] A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy
    Forbes, Geoffrey M.
    Sturm, Marian J.
    Leong, Rupert W.
    Sparrow, Miles P.
    Segarajasingam, Dev
    Cummins, Adrian G.
    Phillips, Michael
    Herrmann, Richard P.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (01) : 64 - 71
  • [9] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
    Herrlinger, Klaus R.
    Stange, Eduard F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11): : 1086 - 1086
  • [10] Dynamics of Proinflammatory Cytokines in Patients With Crohn's Disease Who Received Combined Therapy With Mesenchymal Stromal Cells and Azathioprine
    Oleg, Knyazev
    Anna, Kagramanova
    Nina, Fadeeva
    Ekaterina, Dobrolyubova
    Karina, Noscova
    Anatoliy, Konoplyannikov
    Albina, Lishchinskaya
    Asfold, Parfenov
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S18 - S18
12345